XML 34 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows
$ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Operating activities      
Net loss for the year $ (3,024) $ (983) $ (1,711)
Items not involving cash:      
Fair value (gain) on derivative liabilities - warrants 4 (90) (105)
Fair value loss on warrants 0 0 0
Loss on settlement of convertible notes 0 26 13
Interest and convertible accretion 0 72 260
Realized (gain) on sale of marketable securities (189) 0 0
Unrealized (gain) loss on marketable securities 0 (476) (9)
Share-based compensation 1,077 175 117
Cash flows from (used in) operations before changes in working capital (2,132) (1,276) (1,435)
Changes in non-cash working capital      
Other receivable (3) 0 (1)
Prepaid and deposit (38) (1) 0
Accounts payable and accrued liabilities 95 96 (185)
Cash used in operating activities (2,078) (1,181) (1,621)
Financing activities      
Proceeds from shares issued for private placements, net 3,966 19 132
Proceeds from shares issued for stock options and warrants exercised 323 0  
Convertible notes 0 (381) 0
Loan 0 0 (311)
Related party loan payable 0 0 (218)
Cash provided by financing activities 4,289 (362) (397)
Investing activities      
Expenditures on mineral properties (3,899) (1,411) (1,899)
Net proceeds from water rights sale 1,000 1,868 5,685
Sale Of Marketable Securities (830) 0 0
Reclamation bonds 0 0 28
Cash provided by in investing activities (2,069) 457 3,814
Effect of foreign exchange on cash (1) (25) (31)
(Decrease) increase in cash and cash equivalents 141 (1,111) 1,765
Cash and cash equivalents, beginning of year 701 1,812 47
Cash and cash equivalents, end of year 842 701 1,812
Supplemental cash flow information      
Exploration expenditures included in accounts payable (27) 41 27
Interest paid in cash 0 76 46
Shares issued for interest 0 0 45
Shares issued in settlement agreements $ 27 $ 0 $ 0